Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

RATIONALE: Recent clinical trials are reporting marked improvements in mental health outcomes with psychedelic drug-assisted psychotherapy. OBJECTIVES: Here, we report on safety and efficacy outcomes for up to 6 months in an open-label trial of psilocybin for treatment-resistant depression. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Curran, H. V., Nutt, D. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813086/
https://www.ncbi.nlm.nih.gov/pubmed/29119217
http://dx.doi.org/10.1007/s00213-017-4771-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813086/
https://www.ncbi.nlm.nih.gov/pubmed/29119217
http://dx.doi.org/10.1007/s00213-017-4771-x

Ejemplares similares